Tolley Health Economics Ltd specialises in providing project-based services to the Pharmaceutical industry in four main areas:
(i.e. the National Institute for Health and Clinical Excellence (NICE), the Scottish Medicines Consortium (SMC), the All Wales Medicine Strategy Group (AWMSG) and the National Centre for Pharmacoeconomics (NCPE) in Ireland).
At Tolley Health Economics, we can put together a skilled team using a network of experts to design your utility study for your HTA submissions and/or publication(s).
Over the last decade, the development of Health Economic Models to show positive economic outcomes has become a crucial component to the overall evaluation of a new drug or treatment.
Systematic reviews and meta-analyses are now a key element of evidence-based healthcare and can be used to provide a complete overview of data available to support your HTA submissions.